Trichobilharzia

Trichobilharzia is a genus of trematodes, commonly known as schistosomes. These parasites are primarily found in birds and mammals. The genus includes several species that can cause schistosomiasis, a disease that affects both humans and animals.

Overview

The genus Trichobilharzia belongs to the family Schistosomatidae, which includes other schistosome parasites. These parasites are known for their unique sexual dimorphism, with males being larger and more robust than females. The life cycle of Trichobilharzia involves two hosts: a definitive host, where the parasite reaches maturity and reproduces, and an intermediate host, usually a snail, where the parasite undergoes several developmental stages.

Life Cycle

The life cycle of Trichobilharzia begins when eggs are released into the environment through the feces of the definitive host. These eggs hatch into free-swimming larvae called miracidia, which infect the intermediate host. Inside the snail, the miracidia transform into another larval stage called sporocysts. The sporocysts then produce cercariae, another type of larva, which are released into the water. These cercariae can infect the definitive host by penetrating its skin.

Disease in Humans

Some species of Trichobilharzia can cause a condition known as cercarial dermatitis or swimmer's itch in humans. This is an allergic reaction to the cercariae penetrating the skin. Symptoms include itchy, red bumps and occasionally fever, nausea, and diarrhea. Although the condition is usually self-limiting, severe cases may require medical treatment.

Treatment and Prevention

Treatment for Trichobilharzia infection in humans involves the use of antiparasitic drugs such as praziquantel. Prevention strategies include avoiding contact with contaminated water and controlling snail populations, which are the intermediate hosts of the parasite.

See Also

• Schistosoma
• Schistosomiasis
• Cercarial dermatitis

Trichobilharzia Resources
Need Help Finding a Doctor? WikiMD's DocFinder can help find general and specialist physicians.	Latest articles Most recent articles Ongoing trials.